Search Results

There are 1187 results for: content related to: Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: A randomized placebo-controlled study

  1. You have free access to this content
    Statin-induced inhibition of breast cancer proliferation and invasion involves attenuation of iron transport: intermediacy of nitric oxide and antioxidant defence mechanisms

    The FEBS Journal

    Volume 281, Issue 16, August 2014, Pages: 3719–3738, Anantha Koteswararao Kanugula, Paradesi Naidu Gollavilli, Sathish Babu Vasamsetti, Santosh Karnewar, Raja Gopoju, Ramesh Ummanni and Srigiridhar Kotamraju

    Version of Record online : 30 JUL 2014, DOI: 10.1111/febs.12893

  2. Inhibitory effects of fluvastatin on cytokine and chemokine production by peripheral blood mononuclear cells in patients with allergic asthma

    Clinical & Experimental Allergy

    Volume 36, Issue 4, April 2006, Pages: 475–482, K. T. R. Samson, K. Minoguchi, A. Tanaka, N. Oda, T. Yokoe, Y. Yamamoto, M. Yamamoto, S. Ohta and M. Adachi

    Version of Record online : 24 MAR 2006, DOI: 10.1111/j.1365-2222.2006.02470.x

  3. You have free access to this content
    Fluvastatin reduces oxidative damage in human vascular endothelial cells by upregulating Bcl-2

    Journal of Thrombosis and Haemostasis

    Volume 6, Issue 4, April 2008, Pages: 692–700, S. Z. XU, W. ZHONG, N. M. WATSON, E. DICKERSON, J. D. WAKE, S. W. LINDOW, C. J. NEWTON and S. L. ATKIN

    Version of Record online : 22 JAN 2008, DOI: 10.1111/j.1538-7836.2008.02913.x

  4. Effect of Clopidogrel on the Steady-State Pharmacokinetics of Fluvastatin

    The Journal of Clinical Pharmacology

    Volume 47, Issue 5, May 2007, Pages: 613–619, Surya P. Ayalasomayajula, Sujata Vaidyanathan, Charisse Kemp, Pratapa Prasad, Alfred Balch and William P. Dole

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270006299138

  5. Fluvastatin delays propagation of viral infection in isolated rat FDB myofibers but does not affect exocytic membrane trafficking

    Cell Biology International

    Volume 39, Issue 11, November 2015, Pages: 1307–1316, Mika Nevalainen and Kalervo Metsikkö

    Version of Record online : 27 JUL 2015, DOI: 10.1002/cbin.10509

  6. You have free access to this content
    Involvement of organic anion transporting polypeptides in the toxicity of hydrophilic pravastatin and lipophilic fluvastatin in rat skeletal myofibres

    British Journal of Pharmacology

    Volume 154, Issue 7, August 2008, Pages: 1482–1490, K Sakamoto, H Mikami and J Kimura

    Version of Record online : 29 JAN 2009, DOI: 10.1038/bjp.2008.192

  7. Fluvastatin Reduces Pulmonary Vein Spontaneous Activity Through Nitric Oxide Pathway

    Journal of Cardiovascular Electrophysiology

    Volume 20, Issue 2, February 2009, Pages: 200–206, YU-FENG HU, YAO-CHANG CHEN, CHEN-CHUAN CHENG, SATOSHI HIGA, YI-JEN CHEN and SHIH-ANN CHEN

    Version of Record online : 4 SEP 2008, DOI: 10.1111/j.1540-8167.2008.01281.x

  8. Influence of CYP2C9 polymorphisms on the pharmacokinetics and cholesterol-lowering activity of (−)-3s,5r-fluvastatin and (+)-3r,5s-fluvastatin in healthy volunteers

    Clinical Pharmacology & Therapeutics

    Volume 74, Issue 2, August 2003, Pages: 186–194, Julia Kirchheiner, Dirk Kudlicz, Christian Meisel, Steffen Bauer, Ingolf Meineke, Ivar Roots and Jürgen Brockmöller

    Version of Record online : 5 AUG 2003, DOI: 10.1016/S0009-9236(03)00121-8

  9. You have free access to this content
    Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis

    Arthritis & Rheumatism

    Volume 56, Issue 6, June 2007, Pages: 1827–1835, Yoshisuke Haruna, Yoshitaka Morita, Toyotaka Yada, Minoru Satoh, David A. Fox and Naoki Kashihara

    Version of Record online : 25 MAY 2007, DOI: 10.1002/art.22632

  10. An open-label randomized controlled study of pegylated interferon/ribavirin combination therapy for chronic hepatitis C with versus without fluvastatin

    Journal of Viral Hepatitis

    Volume 19, Issue 9, September 2012, Pages: 615–622, C. Kondo, M. Atsukawa, A. Tsubota, N. Itokawa, T. Fukuda, Y. Matsushita, H. Kidokoro, T. Kobayashi, Y. Narahara, K. Nakatsuka, H. Kanazawa and C. Sakamoto

    Version of Record online : 9 FEB 2012, DOI: 10.1111/j.1365-2893.2011.01584.x

  11. Liquid chromatography/negative ion electrospray tandem mass spectrometry method for the quantification of fluvastatin in human plasma: validation and its application to pharmacokinetic studies

    Rapid Communications in Mass Spectrometry

    Volume 20, Issue 8, 30 April 2006, Pages: 1225–1230, Ramakrishna V. S. Nirogi, Vishwottam N. Kandikere, Wishu Shrivastava, Koteshwara Mudigonda and Praveen V. Datla

    Version of Record online : 15 MAR 2006, DOI: 10.1002/rcm.2436

  12. You have free access to this content
    Long-term Cardiac Outcomes in Renal Transplant Recipients Receiving Fluvastatin: The ALERT Extension Study

    American Journal of Transplantation

    Volume 5, Issue 12, December 2005, Pages: 2929–2936, H. Holdaas, B. Fellström, E. Cole, G. Nyberg, A.G. Olsson, T.R. Pedersen, S. Madsen, C. Grönhagen-Riska, H.-H. Neumayer, B. Maes, P. Ambühl, A. Hartmann, B. Staffler, A.G. Jardine and on behalf of the Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators

    Version of Record online : 18 NOV 2005, DOI: 10.1111/j.1600-6143.2005.01105.x

  13. You have free access to this content
    Fluvastatin inhibits expression of the chemokine MDC/CCL22 induced by interferon-γ in HaCaT cells, a human keratinocyte cell line

    British Journal of Pharmacology

    Volume 157, Issue 8, August 2009, Pages: 1441–1450, Xu-Feng Qi, Dong-Heui Kim, Yang-Suk Yoon, Jian-Hong Li, Dan Jin, Yung-Chien Teng, Soo-Ki Kim and Kyu-Jae Lee

    Version of Record online : 7 JUL 2009, DOI: 10.1111/j.1476-5381.2009.00311.x

  14. Combination of fluvastatin with pegylated interferon/ribavirin therapy reduces viral relapse in chronic hepatitis C infected with HCV genotype 1b

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue 1, January 2013, Pages: 51–56, Masanori Atsukawa, Akihito Tsubota, Chisa Kondo, Norio Itokawa, Yoshiyuki Narahara, Katsuhisa Nakatsuka, Satomi Hashimoto, Takeshi Fukuda, Yoko Matsushita, Hideko Kidokoro, Tamaki Kobayashi, Hidenori Kanazawa and Choitsu Sakamoto

    Version of Record online : 19 DEC 2012, DOI: 10.1111/j.1440-1746.2012.07267.x

  15. You have free access to this content
    Roles of Different CYP Enzymes in the Formation of Specific Fluvastatin Metabolites by Human Liver Microsomes

    Basic & Clinical Pharmacology & Toxicology

    Volume 105, Issue 5, November 2009, Pages: 327–332, Takaki Toda, Erik Eliasson, Birgitta Ask, Nobuo Inotsume and Anders Rane

    Version of Record online : 6 AUG 2009, DOI: 10.1111/j.1742-7843.2009.00453.x

  16. Fluvastatin inhibits the induction of inducible nitric oxide synthase, an inflammatory biomarker, in hepatocytes

    Hepatology Research

    Volume 43, Issue 7, July 2013, Pages: 775–784, Katsuji Tokuhara, Kozo Habara, Masaharu Oishi, Hirokazu Miki, Yoshito Tanaka, Masaki Kaibori, Mikio Nishizawa, Tadayoshi Okumura and A-Hon Kwon

    Version of Record online : 30 NOV 2012, DOI: 10.1111/hepr.12017

  17. Fluvastatin treatment is not associated with an increased incidence of cancer

    International Journal of Clinical Practice

    Volume 60, Issue 9, September 2006, Pages: 1028–1034, E. A. STEIN, A. CORSINI, C. R. GIMPELEWICZ, M. BORTOLINI and M. GIL

    Version of Record online : 10 AUG 2006, DOI: 10.1111/j.1742-1241.2006.01071.x

  18. You have free access to this content
    Apoptosis of rheumatoid synovial cells by statins through the blocking of protein geranylgeranylation: A potential therapeutic approach to rheumatoid arthritis

    Arthritis & Rheumatism

    Volume 54, Issue 2, February 2006, Pages: 579–586, Takao Nagashima, Hitoaki Okazaki, Kazuo Yudoh, Hiroaki Matsuno and Seiji Minota

    Version of Record online : 30 JAN 2006, DOI: 10.1002/art.21564

  19. Biosensing of arteriosclerotic nanoplaque formation and interaction with an HMG-CoA reductase inhibitor

    Acta Physiologica Scandinavica

    Volume 176, Issue 2, October 2002, Pages: 131–145, C. Abletshauser, D. KlÜßEndorf, A. Schmidt, K. Winkler, W. MÄrz, E. Buddecke, M. Malmsten and G. Siegel

    Version of Record online : 27 SEP 2002, DOI: 10.1046/j.1365-201X.2002.01020.x

  20. Differential effects of fluvastatin alone or in combination with ezetimibe on lipoprotein subfractions in patients at high risk of coronary events

    European Journal of Clinical Investigation

    Volume 40, Issue 3, March 2010, Pages: 187–194, T. Stojakovic, A. De Campo, H. Scharnagl, H. Sourij, I. Schmölzer, T. C. Wascher and W. März

    Version of Record online : 7 JAN 2010, DOI: 10.1111/j.1365-2362.2009.02249.x